Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
8,434 | Dovepress* | 5,824 | 1,232+ | 1,284 | 7,056 |
PubMed Central* | 0 | 1,378 | 462 | 1,378 | |
Totals | 5,824 | 2,610 | 1,746 | 8,434 | |
*Since 22 August 2018 +Since July 2016 |
View citations on PubMed Central and Google Scholar